-
ICD-10-CM Codes
›
-
D50-D89
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
›
-
D60-D64
Aplastic and other anemias and other bone marrow failure syndromes
›
-
D64-
Other anemias
›
-
2023 ICD-10-CM Diagnosis Code D64.81
2023 ICD-10-CM Diagnosis Code D64.81
Anemia due to antineoplastic chemotherapy
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- D64.81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM D64.81 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D64.81 - other international versions of ICD-10 D64.81 may differ.
Applicable To- Antineoplastic chemotherapy induced anemia
Type 2 ExcludesType 2 Excludes Help
A type 2 excludes note represents "not included here". A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code (D64.81) and the excluded code together.
The following code(s) above
D64.81 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
D64.81:
- Anemia due to chemotherapy
ICD-10-CM D64.81 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
- 811 Red blood cell disorders with mcc
- 812 Red blood cell disorders without mcc
Convert D64.81 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
Code annotations containing back-references to D64.81:
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) D64.9
ICD-10-CM Diagnosis Code D64.9
Anemia, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- due to (in) (with)
- antineoplastic chemotherapy D64.81
- chemotherapy, antineoplastic D64.81
ICD-10-CM Codes Adjacent To D64.81
D63.0 Anemia in neoplastic disease
D63.1 Anemia in chronic kidney disease
D63.8 Anemia in other chronic diseases classified elsewhere
D64.0 Hereditary sideroblastic anemia
D64.1 Secondary sideroblastic anemia due to disease
D64.2 Secondary sideroblastic anemia due to drugs and toxins
D64.3 Other sideroblastic anemias
D64.4 Congenital dyserythropoietic anemia
D64.8 Other specified anemias
D64.81
Anemia due to antineoplastic chemotherapy
D64.89 Other specified anemias
D64.9 Anemia, unspecified
D65 Disseminated intravascular coagulation [defibrination syndrome]
D66 Hereditary factor VIII deficiency
D67 Hereditary factor IX deficiency
D68 Other coagulation defects
D68.0 Von Willebrand disease
D68.02 Von Willebrand disease, type 2
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
